For example, in head and neck tumors, the ERK1/2-Nanog signaling pathway promotes CSCs phenotyping together with epithelial-mesenchymal transition process, enhancing RT resistance and metastasis [21]. This evidence concerns the gene MAPK3 and head and neck neoplasm.